which licensed it to the Bill & Melinda Gates Medical Research Institute (Gates MRI) in 2020. If effective, it could potentially become the first new vaccine for preventing pulmonary TB ...

"One of my lung lobes had to be removed, and I was placed on a ventilator — to this day, I deal with chronic chest pain..." ...

AbbVie (NYSE: ABBV) today announced that the European Commission (EC) granted marketing authorization to RINVOQ� (upadacitinib; 15 mg, once daily) for the treatment of giant cell arteritis (GCA) in ...

RINVOQ is the first and only oral Janus kinase (JAK) inhibitor approved in the European Union (EU) to treat adult patients with giant cell arteritis (GCA) The approval ...

Tuberculosis (TB) has been a serious health challenge globally. Its cases in India are also increasing the pressure on the ...

The primary aim of the study was to evaluate the diagnostic accuracy of AI in detecting pulmonary TB and to measure its alignment with expert radiologists’ interpretations. The findings were ...

Learn the benefits and limitations of a full-body MRI scan. Discover if it's right for cancer detection and when healthcare ...

European tuberculosis surveillance report underscores the gravity of the situation in the WHO European region.1 Across 53 ...

An advantage of whole-body MRIs over CTs is that they use magnets and radio waves, which eliminate the type of radiation ...

Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients ...

tuberculosis), most frequently affecting the lungs. These tiny bacteria are usually passed on through mucus in the same way as colds are passed on, such as when people sneeze, talk or cough.

Tuberculosis (TB) is an infectious disease caused by strains of bacteria known as mycobacteria. The disease most commonly affects the lungs and can be fatal if not treated. However, most infected ...